161 results
Page 3 of 9
8-K
EX-99.1
5b1106v w2r6zv
5 Aug 14
Discovery Labs Reports Second Quarter 2014 Financial Results
12:00am
424B5
42xgvh z9xg0g9krj
31 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
haq1eh3rp7g9tlt5xnk
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
ihbikzq4rgruef2 9w
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
qd5o6 k2jd6
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
424B5
ypkt6rlpnu0m69
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
ija8 g8syx
13 Mar 13
Discovery Labs Reports Fourth Quarter 2012 Financial Results
12:00am
424B5
t8hnc3rp5gq240r8 ux
13 Feb 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
7zbrm 3bnqlquwls2y
4 Jan 13
Discovery Labs Announces Changes to Board of Directors and Appoints a New Chief Executive Officer
12:00am